Although CD105+ MSCs are known to be superior to unselected MSCs in regeneration of post-infarction heart [26,27], the effect of reduced expression of CD105 in culture using STK2 on therapeutic efficacy needs further investigation. This evidence concerns the gene ENG and infarction.